According to a study published in The Lancet, patients with type 2 diabetes who undergo bariatric surgery have better metabolic outcomes than patients treated with drug therapy, regardless of weight loss.
Dr. Francesco Rubino, MD, of King’s College London, and his colleagues observed 5-year outcomes for 53 overweight patients suffering from type 2 diabetes. Each patient was randomly selected to undergo gastric bypass or biliopancreatic diversion, or continue with drug therapy.
Results concluded that the patients who had undergone surgical procedures lost more weight than medically treated patients, but the change in weight was not indicative of diabetes remission or relapse after surgery.
Approximately half of the 38 surgery patients maintained diabetes remission, compared with zero of the 15 patients in the drug therapy section. Relapse of hyperglycemia was reported in 53% of patients who sustained 2-year remission in the gastric bypass group and roughly 37% of the patients who achieved 2-year remission in the biliopancreatic diversion group.
“The ability of surgery to greatly reduce the need for insulin and other drugs suggests that surgical therapy is a cost-effective approach to treating type 2 diabetes,” said Rubino in a news release from King’s College London, where he is chair of bariatric and metabolic surgery.
For more information on this study, visit The Lancet.
CarePoint Health Bariatric Surgery
CarePoint Health Center for Bariatric Surgery offers a number of different weight-loss surgeries to help you meet your weight-loss goals, including sleeve gastrectomy, and Roux-en-Y gastric bypass surgery, LAP-BAND®, and REALIZE® Band. To learn more about our bariatric surgery options, contact us at 201-795-8175 and register for our free seminar.
Content on our website is for informational purposes only and does not constitute medical advice. If you are experiencing a medical emergency, please call 911. Always consult your physician before making any changes to your medical treatment.